The Technical Analyst
BIG PHARMA SPLIT CORP [PRM.TO]
Exchange: TSX Industry: Asset Management
BIG PHARMA SPLIT CORP Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $13.85
America/New_York / 1 mai 2024 @ 15:01
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 16.11 mill |
| EPS: | -0.530 |
| P/E: | -26.13 |
| Earnings Date: | N/A |
| SharesOutstanding: | 1.164 mill |
| Avg Daily Volume: | 0.0012 mill |
| RATING 2024-05-01 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | n/a | n/a | |||
| Ebit | n/a | n/a | n/a | |||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -26.13 | sector: PE 21.44 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.35x |
| Company: PE -26.13 | industry: PE 73.86 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-7.66 (-155.28%) $-21.51 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
$ 13.66 - 14.04 ( +/- 1.35%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $13.85 (0.00% ) |
| Volume | 0.0011 mill |
| Avg. Vol. | 0.0012 mill |
| % of Avg. Vol | 90.92 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PRM.TO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PRM.TO
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.